Target intelligence / Profile preview

Morphine

Molecular classification
Other
01

Overview

Morphine is **not a target molecule or receptor**; it is a small-molecule drug classified as a natural opium alkaloid and the principal active compound of opium[1][3][5][9]. Morphine acts pharmacologically as a classic opioid analgesic by binding to and activating opioid receptors—primarily the mu-opioid receptor—in the central and peripheral nervous systems to block pain transmission[2][6][7]. It is used to manage moderate to severe pain and has been foundational in the development of both opioid receptor pharmacology and analgesic drug development. As such, morphine is a **ligand (drug)**, not a therapeutic target (such as a receptor, enzyme, or transporter) and should not be catalogued as a drug target[2][3][7].\n\n**Note:**\n- If you are seeking information about morphine's primary therapeutic target, it is the **mu-opioid receptor** (sometimes abbreviated as MOR or OPRM1), which is a G protein-coupled receptor involved in pain modulation and other physiological processes[2][6][7].\n- For structured information, please use the **mu-opioid receptor** as the canonical therapeutic target in drug-target databases.

Other names
(−)-morphineMorfinaMorphiaMorphinMorphinumMorphiumAnhydrous morphine

Beyond the preview

Go deeper on Morphine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Morphine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call